Norway· NO-ID_56B96902-83E4-468B-BCA3-59BD780EB674
Bexsero
A meningokokkus b, multikomponenten-impfstoff product containing aluminium hydroxide, recombinant neisseria meningitidis group b nhba fusion protein produced in e. coli cells by recombinant dna technology adsorbed on aluminium hydroxide, recombinant neisseria meningitidis group b nada protein produced in e. coli cells by recombinant dna technology adsorbed on aluminium hydroxide, recombinant neisseria meningitidis group b fhbp fusion protein produced in e. coli cells by recombinant dna technology adsorbed on aluminium hydroxide, outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 adsorbed on aluminium hydroxide, registered in Norway by GSK Vaccines S.r.l.. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Meningokokkus b, multikomponenten-impfstoff is registered in 11 of 19 countries.
Countries holding a registration under ATC J07AH09 (meningokokkus b, multikomponenten-impfstoff), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Meningokokkus b, multikomponenten-impfstoff · ATC J07AH09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Aluminium Hydroxide, Recombinant Neisseria Meningitidis Group B Nhba Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide, Recombinant Neisseria Meningitidis Group B Nada Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide, Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide, Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
- Manufacturer
- GSK Vaccines S.r.l.
- Country
- Norway (NO)
- ATC code
- J07AH09
- ATC class
- Meningokokkus B, Multikomponenten-Impfstoff
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_56B96902-83E4-468B-BCA3-59BD780EB674
- no_varenummer4846940.5NOK 996.8
- gtin4779027331072
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH09
Meningokokkus b, multikomponenten-impfstoff, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1f4b5d4-3bfe-4807-bbce-712f7f3be56a GET /v1/drugs/e1f4b5d4-3bfe-4807-bbce-712f7f3be56a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, suspensjon i ferdigfylt sprøyte",
"source": "fest",
"status": "A",
"atc_name": "Meningokokk B, mulitkomponent vaksine",
"merkevare_id": "ID_56B96902-83E4-468B-BCA3-59BD780EB674",
"name_form_strength": "Bexsero inj væske, susp",
"prescription_group": "C"
}See everything about meningokokkus b, multikomponenten-impfstoff.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.